Cases & Deals

Sanofi and Lonza form joint venture to establish large-scale biologics production facility in Switzerland

Clients Sanofi

Jones Day advised Sanofi in the formation of a joint venture with Lonza Group AG to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland. The initial investment will be around €270 million (US$285 million), to be split equally between each company.

In addition to M&A representation, Jones Day provided antitrust advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.